1. Chemical tools for modulating autophagy
   Gemma Triola, 2015, Tetrahedron CrossRef
2. Study on synthesizing the complex of sorafenib with 2-hydroxypropyl-β-cyclodextrin to enhance the anticancer activity of the drug substance
   Van Cuong Bui et al, 2024, Pure and Applied Chemistry CrossRef
3. Therapeutic approaches for the treatment of head and neck squamous cell carcinoma–An update on clinical trials
   Bharat Goel et al, 2022, Translational Oncology CrossRef
4. Role of Molecular Targeted Therapeutic Drugs in Treatment of Oral Squamous Cell Carcinoma: Development and Current Strategies—A Review Article
   Himanshu Singh et al, 2022, Global Medical Genetics CrossRef
5. Novel spectrophotometric and factor-based multivariate calibration-prediction techniques for determination of two inhibitors of hepatitis C-virus and hepatocellular carcinoma in pure, human urine, and human plasma
   Dalia W. Zidan et al, 2019, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy CrossRef
6. U0126 Protects Cells against Oxidative Stress Independent of Its Function as a MEK Inhibitor
   Qunxiang Ong et al, 2015, ACS Chemical Neuroscience CrossRef
7. Sorafenib inhibits ovarian cancer cell proliferation and mobility and induces radiosensitivity by targeting the tumor cell epithelial–mesenchymal transition
   Chuntao Tian et al, 2022, Open Life Sciences CrossRef
8. Mechanism and function of miR-140 in human cancers: A review and in silico study
   Forough Taheri et al, 2023, Pathology - Research and Practice CrossRef
9. Pyrazine Moiety: Recent Developments in Cancer Treatment
   Rakesh Sahu et al, 2023, Current Organic Chemistry CrossRef
10. Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas
    Xiaofan Lu et al, 2023, Cell Reports Medicine CrossRef
11. 1,3-Dichloroadamantyl-Containing Ureas as Potential Triple Inhibitors of Soluble Epoxide Hydrolase, p38 MAPK and c-Raf
    Boris P. Gladkikh et al, 2023, International Journal of Molecular Sciences CrossRef
12. Synthesis of newN,N′-Pd(Pt) complexes based on sulfanyl pyrazoles, and investigation of theirin vitroanticancer activity
    Vnira R. Akhmetova et al, 2020, RSC Advances CrossRef
13. Autophagy and salivary gland cancer: A putative target for salivary gland tumors
    Evangelos Koustas et al, 2020, Tumor Biology CrossRef
14. Efficacy of low dose capecitabine and sorafenib in patients with advanced alfa-fetoprotein secreting hepatocellular carcinoma: a 1 year experience
    Amr Shaaban Hanafy, 2016, SpringerPlus CrossRef
15. Protein kinase inhibitors for acute leukemia
    Yuan Ling et al, 2018, Biomarker Research CrossRef
16. Ferroptosis and Cancer: Mitochondria Meet the “Iron Maiden” Cell Death
    Anna Martina Battaglia et al, 2020, Cells CrossRef
17. Theoretical investigation of fullerene (C60) as nano carrier for anti-cancer drug Axitinib
    Saied Jamaladdin Emamjome Koohbanani et al, 2024, Carbon Trends CrossRef
18. Determination of the Anticancer Drug Sorafenib in Serum by Adsorptive Stripping Differential Pulse Voltammetry Using a Chitosan/Multiwall Carbon Nanotube Modified Glassy Carbon Electrode
    Nurgul Karadas‐Bakirhan et al, 2016, Electroanalysis CrossRef
19. RASSF6-mediated inhibition of Mcl-1 through JNK activation improves the anti-tumor effects of sorafenib in renal cell carcinoma
    Ying-Ying Liang et al, 2018, Cancer Letters CrossRef
20. Autophagy regulates Selumetinib (AZD6244) induced-apoptosis in colorectal cancer cells
    Silvina Grasso et al, 2016, European Journal of Medicinal Chemistry CrossRef
21. Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols
    Danijel Galun, 2015, World Journal of Hepatology CrossRef